1Department of Neurosurgery, Mount Sinai Health System, New York, New York.
2Department of Anesthesiology, University of Minnesota, Minneapolis, Minnesota.
J Neurosurg. 2021 Jul 2;136(1):134-147. doi: 10.3171/2020.12.JNS203778. Print 2022 Jan 1.
Rescue therapies have been recommended for patients with angiographic vasospasm (aVSP) and delayed cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH). However, there is little evidence from randomized clinical trials that these therapies are safe and effective. The primary aim of this study was to apply game theory-based methods in explainable machine learning (ML) and propensity score matching to determine if rescue therapy was associated with better 3-month outcomes following post-SAH aVSP and DCI. The authors also sought to use these explainable ML methods to identify patient populations that were more likely to receive rescue therapy and factors associated with better outcomes after rescue therapy.
Data for patients with aVSP or DCI after SAH were obtained from 8 clinical trials and 1 observational study in the Subarachnoid Hemorrhage International Trialists repository. Gradient boosting ML models were constructed for each patient to predict the probability of receiving rescue therapy and the 3-month Glasgow Outcome Scale (GOS) score. Favorable outcome was defined as a 3-month GOS score of 4 or 5. Shapley Additive Explanation (SHAP) values were calculated for each patient-derived model to quantify feature importance and interaction effects. Variables with high SHAP importance in predicting rescue therapy administration were used in a propensity score-matched analysis of rescue therapy and 3-month GOS scores.
The authors identified 1532 patients with aVSP or DCI. Predictive, explainable ML models revealed that aneurysm characteristics and neurological complications, but not admission neurological scores, carried the highest relative importance rankings in predicting whether rescue therapy was administered. Younger age and absence of cerebral ischemia/infarction were invariably linked to better rescue outcomes, whereas the other important predictors of outcome varied by rescue type (interventional or noninterventional). In a propensity score-matched analysis guided by SHAP-based variable selection, rescue therapy was associated with higher odds of 3-month GOS scores of 4-5 (OR 1.63, 95% CI 1.22-2.17).
Rescue therapy may increase the odds of good outcome in patients with aVSP or DCI after SAH. Given the strong association between cerebral ischemia/infarction and poor outcome, trials focusing on preventative or therapeutic interventions in these patients may be most able to demonstrate improvements in clinical outcomes. Insights developed from these models may be helpful for improving patient selection and trial design.
血管痉挛(aVSP)和迟发性脑缺血(DCI)是蛛网膜下腔出血(SAH)的常见并发症,推荐对这些患者进行血管再通治疗。然而,随机临床试验几乎没有证据表明这些治疗方法是安全有效的。本研究的主要目的是应用基于博弈论的方法和倾向评分匹配,确定血管再通治疗是否与 aVSP 和 DCI 后 3 个月的结局改善相关。作者还试图使用这些可解释的机器学习方法,确定更有可能接受血管再通治疗的患者人群,以及血管再通治疗后结局改善的相关因素。
从蛛网膜下腔出血国际试验库中的 8 项临床试验和 1 项观察性研究中获得 aVSP 或 DCI 后患者的数据。为每位患者构建梯度提升机器学习模型,预测接受血管再通治疗的概率和 3 个月格拉斯哥预后量表(GOS)评分。良好的结局定义为 3 个月 GOS 评分为 4 或 5。为每位患者衍生模型计算 Shapley 加性解释(SHAP)值,以量化特征重要性和交互效应。在预测血管再通治疗的倾向评分匹配分析中,使用预测值高的变量,分析血管再通治疗与 3 个月 GOS 评分的关系。
作者共纳入 1532 例 aVSP 或 DCI 患者。可解释的预测性机器学习模型显示,动脉瘤特征和神经并发症,而不是入院时的神经评分,对预测是否进行血管再通治疗具有最高的相对重要性排名。年龄较小和无脑缺血/梗死始终与更好的血管再通治疗结局相关,而其他重要的结局预测因素因再通类型(介入性或非介入性)而异。在基于 SHAP 变量选择的倾向评分匹配分析中,血管再通治疗与 3 个月 GOS 评分 4-5 的几率增加相关(OR 1.63,95%CI 1.22-2.17)。
血管再通治疗可能会增加 aVSP 或 DCI 后 SAH 患者良好结局的几率。鉴于脑缺血/梗死与不良结局之间存在很强的关联,针对这些患者的预防性或治疗性干预的试验可能最有能力显示临床结局的改善。从这些模型中获得的见解可能有助于改善患者选择和试验设计。